Skip to main content

Forma Therapeutics Holdings, Inc.

FMTXDelisted Oct 14, 2022
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001538927

Forma Therapeutics Holdings, Inc. was delisted on Oct 14, 2022; its insiders filed their last Form 4 on Oct 14, 2022; 139 institutions reported holding it in 13F filings for Q3 2022, worth $835.0M in total; HHLR Advisors (Hillhouse) was the only superinvestor holding it.

Q2 2021 vs. Q1 2021

How the institutions holding Forma Therapeutics Holdings, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of FMTX: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders8783−4
Shares40.5M40.4M−171.1K (−0.4%)
Value$1.14B$1.00B−$131.4M (−11.6%)

New holders (13)

Institutions that held Forma Therapeutics Holdings, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to FMTX in Q2 2021
InstitutionSharesValue% of portfolio
Opaleye Management Inc.171,000$4.26M0.71%
EcoR1 Capital, LLC105,638$2.63M0.10%
Integral Health Asset Management, LLC45,000$1.12M0.31%
Squarepoint Ops LLC21,375$532.0K0.00%
Virginia Retirement Systems Et Al16,900$421.0K0.00%
Susquehanna Fundamental Investments, LLC13,155$327.0K0.01%
Invesco Ltd.12,387$308.0K0.00%
Matisse Capital10,500$261.0K0.08%
Silverarc Capital Management, LLC9,679$241.0K0.13%
Cubist Systematic Strategies, LLC9,102$227.0K0.00%
Group One Trading, L.P.200$5.00K0.00%
TCI Wealth Advisors, Inc.96$2.00K0.00%
Signaturefd, LLC29$1.00K0.00%

Sold out (17)

Institutions that held Forma Therapeutics Holdings, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.